417 related articles for article (PubMed ID: 33481663)
1. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
Cancer Cell Int; 2020; 20():472. PubMed ID: 33005105
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
4. A Genomic-Clinicopathologic Nomogram Predicts Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wen Q; Tan X; Chen Z; Liu G
Dis Markers; 2019; 2019():5980567. PubMed ID: 31827637
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Tan X; Yang H; Chen J; Liu G
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744320
[TBL] [Abstract][Full Text] [Related]
6. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
7. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract][Full Text] [Related]
8. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
[TBL] [Abstract][Full Text] [Related]
9. Low expression of miR-20b-5p indicates favorable prognosis in laryngeal squamous cell carcinoma, especially in patients with non-infiltrated regional lymph nodes.
Pantazis TL; Giotakis AI; Karamagkiolas S; Giotakis I; Konstantoulakis M; Liakea A; Misiakos EP
Am J Otolaryngol; 2020; 41(5):102563. PubMed ID: 32521298
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
11. CCT α is a novel biomarker for diagnosis of laryngeal squamous cell cancer.
Yang J; Zhang Z; Zhao Y; Cheng J; Zhao C; Wang Z
Sci Rep; 2019 Aug; 9(1):11823. PubMed ID: 31413263
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression.
Liu DM; Yang H; Yuan ZN; Yang XG; Pei R; He HJ
Biochem Biophys Res Commun; 2020 Aug; 529(2):148-155. PubMed ID: 32703403
[TBL] [Abstract][Full Text] [Related]
14.
Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of neuropilin-2 expression in laryngeal squamous cell carcinoma.
Yin D; Guo L; Li S; Tuerdi A; Yang X; Tang Q; Wang S; Liu J; Huang P; Li M
Am J Otolaryngol; 2020; 41(4):102540. PubMed ID: 32480134
[TBL] [Abstract][Full Text] [Related]
16. Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.
Sun M; Chen S; Fu M
Medicine (Baltimore); 2021 Jan; 100(2):e24263. PubMed ID: 33466212
[TBL] [Abstract][Full Text] [Related]
17. An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.
Chen D; Wang M; Guo Y; Wu W; Ji X; Dou X; Tang H; Zong Z; Zhang X; Xiong D
Cancer Med; 2021 Sep; 10(17):5936-5947. PubMed ID: 34313009
[TBL] [Abstract][Full Text] [Related]
18. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
[TBL] [Abstract][Full Text] [Related]
20. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
